AR and prostate cancer: Previously, we demonstrated that androgen/AR signaling increases prostate cancer cell proliferation, while simultaneously inhibiting cancer cell migration, which is induced by the activation of several C-C motif ligand (CCL)-receptor (CCR) axes downstream or upstream of androgen/AR signaling [9,10,11,12].